NCT00399152View on ClinicalTrials.gov

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

October 31, 2009

Conditions

Renal CancerGIST

Interventions

DRUG

Perifosine

Perifosine Oral Dose

DRUG

Sunitinib Malate

Sunitinib oral dose

Sponsors

Lead Sponsor

AEterna Zentaris

All Listed Sponsors

lead

AEterna Zentaris

INDUSTRY